Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Sirolimus

EU orphan designation number: EU/3/15/1557   
Active ingredient: Sirolimus
Indication: Treatment of tuberous sclerosis
Sponsor: Desitin Arzneimittel GmbH
Weg beim Jäger 214, 22335 Hamburg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/10/2015 Orphan designation EMA/OD/100/15 (2015)7028 of 9/10/2015